Inner Mongolia Furui Medical Science Co., Ltd. (INNER MONGOLIA FURUI MEDICAL SC) aksje
300049.SZ
StengtINNER MONGOLIA FURUI MEDICAL SC
Market Cap
$11,523,802,112
Om Inner Mongolia Furui Medical Science Co., Ltd. (INNER MONGOLIA FURUI MEDICAL SC) aksje
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Selskapsinformasjon
100020 Beijing, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.